Full-reference image quality measures are a fundamental tool to approximate the human visual system in various applications for digital data management: from retrieval to compression to detection of unauthorized uses. Inspired by both the effectiveness and the simplicity of hand-crafted Structural Similarity Index Measure (SSIM), in this work, we present a framework for the formulation of SSIM-like image quality measures through genetic programming. We explore different terminal sets, defined from the building blocks of structural similarity at different levels of abstraction, and we propose a two-stage genetic optimization that exploits hoist mutation to constrain the complexity of the solutions. Our optimized measures are selected through a cross-dataset validation procedure, which results in superior performance against different versions of structural similarity, measured as correlation with human mean opinion scores. We also demonstrate how, by tuning on specific datasets, it is possible to obtain solutions that are competitive with (or even outperform) more complex image quality measures.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TIP.2023.3244662DOI Listing

Publication Analysis

Top Keywords

image quality
16
quality measures
12
structural similarity
12
full-reference image
8
genetic programming
8
quality
4
quality expression
4
expression genetic
4
programming full-reference
4
measures
4

Similar Publications

Background: Acute respiratory distress syndrome (ARDS) is a serious threat to human life. Hence, early and accurate diagnosis and treatment are crucial for patient survival. This meta-analysis evaluates the accuracy of artificial intelligence in the early diagnosis of ARDS and provides guidance for future research and applications.

View Article and Find Full Text PDF

Background: Tumour hypoxia resulting from inadequate perfusion is common in many solid tumours, including prostate cancer, and constitutes a major limiting factor in radiation therapy that contributes to treatment resistance. Emerging research in preclinical animal models indicates that exercise has the potential to enhance the efficacy of cancer treatment by modulating tumour perfusion and reducing hypoxia; however, evidence from randomised controlled trials is currently lacking. The 'Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE' (ERADICATE) study is designed to investigate the impact of exercise on treatment response, tumour physiology, and adverse effects of treatment in prostate cancer patients undergoing external beam radiation therapy (EBRT).

View Article and Find Full Text PDF

Background: Hematopoietic stem cell transplantation (HSCT) is a common therapy for many hematologic malignancies. While advances in transplant practice have improved cancer-specific outcomes, multiple and debilitating long term physical and psychologic effects remain. Patients undergoing allogeneic bone marrow transplantation (allo-BMT) are often critically ill at initial diagnosis and with necessary sequential treatments become increasingly frail and deconditioned.

View Article and Find Full Text PDF

Templates for the acquisition of large datasets such as the Human Connectome Project guide the neuroimaging community to reproducible data acquisition and scientific rigor. By contrast, small animal neuroimaging often relies on laboratory-specific protocols, which limit cross-study comparisons. The establishment of broadly validated protocols may facilitate the acquisition of large datasets, which are essential for uncovering potentially small effects often seen in functional MRI (fMRI) studies.

View Article and Find Full Text PDF

Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment.

Nat Rev Cardiol

January 2025

Cardioncology Unit, Cardioncology and Second Opinion Division, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.

Anthracyclines are the cornerstone of treatment for many malignancies. However, anthracycline cardiotoxicity is a considerable concern given that it can compromise the clinical effectiveness of the treatment and patient survival despite early discontinuation of therapy or dose reduction. Patients with cancer receiving anthracycline treatment can have a reduction in their quality of life and likelihood of survival due to cardiotoxicity, irrespective of their oncological prognosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!